NASDAQ: MRNA · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

Moderna Inc.

How Moderna Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$88.9B

Price

$222.76

P/E

-28.2

EPS (TTM)

$-7.90

1-year return

691.6%

Dividend yield

0.0%

52-week range

$22.36–$245.81

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector
• S&P 500
• NASDAQ-100

For information only, not investment advice. Data may contain errors. Disclaimer · Sources